Source: Google NewsPublished on 2022-08-01
Related Articles:
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- Outset Medical pauses at-home dialysis shipments, sending stock to all-time low - FierceBiotech June 15, 2022 Outset Medical pauses at-home dialysis shipments, sending stock to all-time low FierceBiotech
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Machine Learning to Identify Dialysis Patients at High Death Risk. September 14, 2019 Machine Learning to Identify Dialysis Patients at High Death Risk. Kidney Int Rep. 2019 Sep;4(9):1219-1229 Authors: Akbilgic O, Obi Y, Potukuchi PK, Karabayir I, Nguyen DV, Soohoo M, Streja E, Molnar MZ, Rhee CM, Kalantar-Zadeh K, Kovesdy CP Abstract Introduction: Given the high mortality rate within the first year of dialysis initiation, an accurate estimation of postdialysis mortality could help…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Faith, Medical Science & the FDA June 28, 2021 I’ve never been devout. I was raised in a secular Jewish home. For my parents being Jewish meant a connection to a people, not to any creed or book. I owe my life to that distinction. Most of my great grandparents were devoutly religious. When the Nazis occupied Poland in 1939 their children, my grandparents, saw the writing on the…
- Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
- FDA: Data Manipulation Reported in Recently Approved Gene Therapy for SMA August 7, 2019 According to the Food and Drug Administration (FDA), AveXis Inc, the manufacturer of the gene therapy Zolgensma, was aware of an issue related to “data manipulation” prior to approval, but did not inform the Agency until after the product was approved. In a press release, Peter Marks, MD, PhD, director of FDA’s Center for Biologics Evaluation and Research stated that…
- Monthly Research Review – July 2021 July 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during July 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
- Lower back pain and Parkinson’s disease August 24, 2021 Lower back pain and Parkinson’s disease Lower back pain is an extremely common problem in the general population, as well as for people with Parkinson’s disease (PD). It tends to make moving more difficult, adding to the challenges of PD. Tim Nordahl, PT, DPT, a physical therapist at Boston University gave an excellent presentation as part of APDA’s Let’s Keep…
- Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
- 'Sunday Morning Futures' on Biden's mental capacity, Jill Biden comparing Latinos to tacos August 1, 2022 This is a rush transcript from "Sunday Morning Futures" July 17, 2022. This copy may not be in its final form and may be updated.MARIA BARTIROMO, FOX NEWS ANCHOR: Good Sunday morning, everyone. Welcome to "Sunday Morning Futures." Thanks so much for joining us. I'm Maria Bartiromo. Today: weakness on the world stage. President Biden coming home from the Middle East…
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- The inflammasome field is heating up December 6, 2019 When a cell is sick or damaged it will send out signals alerting the immune system that something is wrong. If enough of these molecules are released, they will initate an “immune response” and this process is called inflammation. There is evidence in neurodegenerative conditions (like Parkinson’s and Alzheimer’s) that the inflammation process is involved, and inhibitors of particular…
- Rune Labs' Apple Watch-based Parkinson's disease tracker gets FDA clearance - The Verge June 13, 2022 Rune Labs' Apple Watch-based Parkinson's disease tracker gets FDA clearance The VergeRune Labs Secures FDA Clearance for Parkinson's Disease Monitoring through StrivePD Ecosystem on Apple Watch BioSpaceStartup gets green light to use Apple Watch to track Parkinson's symptoms STATRune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms Reuters.comApple Watch Parkinson's monitoring app gets FDA approval for clinical use 9to5Mac
- Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis July 21, 2021 Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902. Online ahead of print.ABSTRACTINTRODUCTION: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.METHODS: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration…
- Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis July 21, 2021 Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902. Online ahead of print.ABSTRACTINTRODUCTION: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.METHODS: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration…
- Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis July 21, 2021 Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902. Online ahead of print.ABSTRACTINTRODUCTION: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.METHODS: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration…
- Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis July 21, 2021 Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902. Online ahead of print.ABSTRACTINTRODUCTION: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.METHODS: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration…
- Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis July 21, 2021 Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902. Online ahead of print.ABSTRACTINTRODUCTION: Hypo- and hyperkalemia are associated with a higher risk of ischemic stroke. However, this association has not been examined in an advanced chronic kidney disease (CKD) population.METHODS: From among 102,477 US veterans transitioning to dialysis between 2007 and 2015, 21,357 patients with 2 pre-dialysis outpatient estimated glomerular filtration…
- Year in review: 2021 December 31, 2021 # # # # As with the preceding year, 2021 proved to be challenging due to the continuing COVID-19 pandemic (and it is not over yet). Vaccines were rolled out with remarkable speed, but equally new variants of the virus popped up and have kept Governments and health regulatory bodies on their toes. An amazing feature of the last two…
- Planning for the What Ifs: Navigating the Future March 30, 2021 Navigating the Future with Advanced Parkinson’s Disease Dr. Gilbert interviews Eleanora Tornatore-Mikesh for her insights on planning for the future with advanced Parkinson’s Today we continue Parkinson’s Disease: Planning for the What Ifs, a special series of posts that discuss the issues of advanced Parkinson’s disease (PD). Additional background about advanced PD and the full introduction to the series is available if you need…